chr5-1877166-A-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_016358.3(IRX4):c.*803T>G variant causes a downstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.273 in 152,158 control chromosomes in the GnomAD database, including 5,840 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 5840 hom., cov: 34)
Consequence
IRX4
NM_016358.3 downstream_gene
NM_016358.3 downstream_gene
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.742
Publications
24 publications found
Genes affected
IRX4 (HGNC:6129): (iroquois homeobox 4) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in cell development; neuron differentiation; and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within heart development. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
IRX4 Gene-Disease associations (from GenCC):
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
- ventricular septal defect 1Inheritance: AD Classification: LIMITED Submitted by: Illumina
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRX4 | NM_016358.3 | c.*803T>G | downstream_gene_variant | ENST00000231357.7 | NP_057442.1 | |||
IRX4 | NM_001278635.2 | c.*803T>G | downstream_gene_variant | NP_001265564.1 | ||||
IRX4 | NM_001278634.2 | c.*803T>G | downstream_gene_variant | NP_001265563.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.273 AC: 41463AN: 152040Hom.: 5834 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
41463
AN:
152040
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.273 AC: 41495AN: 152158Hom.: 5840 Cov.: 34 AF XY: 0.272 AC XY: 20237AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
41495
AN:
152158
Hom.:
Cov.:
34
AF XY:
AC XY:
20237
AN XY:
74390
show subpopulations
African (AFR)
AF:
AC:
13486
AN:
41484
American (AMR)
AF:
AC:
4931
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
810
AN:
3472
East Asian (EAS)
AF:
AC:
1583
AN:
5176
South Asian (SAS)
AF:
AC:
1235
AN:
4830
European-Finnish (FIN)
AF:
AC:
2360
AN:
10586
Middle Eastern (MID)
AF:
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
AC:
16174
AN:
67990
Other (OTH)
AF:
AC:
565
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1600
3199
4799
6398
7998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
947
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.